J Gynecol Oncol.  2020 Sep;31(5):e62. 10.3802/jgo.2020.31.e62.

Incidence and clinical course of septic shock in neutropenic patients during chemotherapy for gynecological cancers

• Yoo J
• Jung Y
• Ahn JH
• Choi YJ
• Lee KH
• Hur S

• KMID: 2511974
• DOI: http://doi.org/10.3802/jgo.2020.31.e62

Abstract

Objective
To identify the incidence and clinical course of septic shock combined with neutropenia during chemotherapy in gynecological cancer patients.
Methods
We retrospectively reviewed the medical records of all gynecological cancer patients who received intravenous chemotherapy between March 2009 and March 2018. Patients diagnosed with neutropenic septic shock (NSS) during the course of chemotherapy were identified. We calculated the overall incidence and mortality rate of NSS, and analyzed risk factors and clinical course.
Results
A total of 1,009 patients received 10,239 cycles of chemotherapy during the study period. Among these, 30 (3.0%) patients had 32 NSS events, of which 12 (1.2%) died. With respect to patient age during the first course of chemotherapy, the incidence of NSS after the age of 50 was significantly higher than that in patients under 50 (3.9% vs. 1.4%, p=0.034). As the number of chemotherapy courses increased, the incidence of NSS increased, and linear-by-linear association analysis showed a positive correlation (p=0.004). NSS events occurred on average 7.8 days after the last cycle of chemotherapy, and the median duration of vasopressor administration was 23.3 hours. The median age (64.0 vs. 56.5, p=0.017) and peak heart rate (149.5 min −1 vs. 123.5 min −1 , p=0.015) were significantly higher in the group of patients who subsequently died of NSS than in those who survived.
Conclusion
The overall incidence of NSS in gynecological cancer patients receiving chemotherapy was 3.0%, which is higher than previously estimated. Peak heart rate during NSS events may be an indicator for predicting survival.

Keyword

Adjuvant Chemotherapy; Chemotherapy-Induced Febrile Neutropenia; Gynecologic Neoplasms; Septic Shock